Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 25 to 36 of 82 entries
Sorted by: Best Match Show Resources per page
Effect of nucleoside analog-interferon sequential therapy on patients with acute exacerbation of chronic hepatitis B.

Hepatology research : the official journal of the Japan Society of Hepatology

Okuse C, Yotsuyanagi H, Yamada N, Okamoto M, Ikeda H, Kobayashi M, Fukuda Y, Takahashi H, Nagase Y, Suzuki Y, Matsunaga K, Ishii T, Matsumoto N, Koike K, Suzuki M, Itoh F.
PMID: 20412327
Hepatol Res. 2010 May;40(5):461-9. doi: 10.1111/j.1872-034X.2010.00639.x. Epub 2010 Apr 14.

AIM: Nucleoside analog (NA)-interferon (IFN) sequential therapy may enable the long-term control of chronic hepatitis B (CHB) and the withdrawal of the nucleoside analog. We evaluated the efficacy of NA-IFN sequential therapy for acute exacerbation of CHB.METHODS: A total...

Cite
Okuse C, Yotsuyanagi H, Yamada N, et al. Effect of nucleoside analog-interferon sequential therapy on patients with acute exacerbation of chronic hepatitis B. Hepatol Res. 2010;40(5):461-9doi: 10.1111/j.1872-034X.2010.00639.x.
Okuse, C., Yotsuyanagi, H., Yamada, N., Okamoto, M., Ikeda, H., Kobayashi, M., Fukuda, Y., Takahashi, H., Nagase, Y., Suzuki, Y., Matsunaga, K., Ishii, T., Matsumoto, N., Koike, K., Suzuki, M., & Itoh, F. (2010). Effect of nucleoside analog-interferon sequential therapy on patients with acute exacerbation of chronic hepatitis B. Hepatology research : the official journal of the Japan Society of Hepatology, 40(5), 461-9. https://doi.org/10.1111/j.1872-034X.2010.00639.x
Okuse, Chiaki, et al. "Effect of nucleoside analog-interferon sequential therapy on patients with acute exacerbation of chronic hepatitis B." Hepatology research : the official journal of the Japan Society of Hepatology vol. 40,5 (2010): 461-9. doi: https://doi.org/10.1111/j.1872-034X.2010.00639.x
Okuse C, Yotsuyanagi H, Yamada N, Okamoto M, Ikeda H, Kobayashi M, Fukuda Y, Takahashi H, Nagase Y, Suzuki Y, Matsunaga K, Ishii T, Matsumoto N, Koike K, Suzuki M, Itoh F. Effect of nucleoside analog-interferon sequential therapy on patients with acute exacerbation of chronic hepatitis B. Hepatol Res. 2010 May;40(5):461-9. doi: 10.1111/j.1872-034X.2010.00639.x. Epub 2010 Apr 14. PMID: 20412327.
Copy Download .nbib Format: NLM
Timing of interferon therapy and sources of infection in patients with acute hepatitis C.

Hepatology research : the official journal of the Japan Society of Hepatology

Ogata K, Ide T, Kumashiro R, Kumada H, Yotsuyanagi H, Okita K, Akahane Y, Kaneko S, Tsubouchi H, Tanaka E, Moriwaki H, Nishiguchi S, Kakumu S, Mizokami M, Iino S, Sata M.
PMID: 16359917
Hepatol Res. 2006 Jan;34(1):35-40. doi: 10.1016/j.hepres.2005.08.012. Epub 2005 Dec 15.

BACKGROUND/AIMS: Controversy over the selection of patients and optimum therapeutic method for acute hepatitis C has continued. The aims of this study were to investigate the source of infection, and to evaluate the timing of interferon (IFN) therapy in...

Cite
Ogata K, Ide T, Kumashiro R, et al. Timing of interferon therapy and sources of infection in patients with acute hepatitis C. Hepatol Res. 2005;34(1):35-40doi: 10.1016/j.hepres.2005.08.012.
Ogata, K., Ide, T., Kumashiro, R., Kumada, H., Yotsuyanagi, H., Okita, K., Akahane, Y., Kaneko, S., Tsubouchi, H., Tanaka, E., Moriwaki, H., Nishiguchi, S., Kakumu, S., Mizokami, M., Iino, S., & Sata, M. (2006). Timing of interferon therapy and sources of infection in patients with acute hepatitis C. Hepatology research : the official journal of the Japan Society of Hepatology, 34(1), 35-40. https://doi.org/10.1016/j.hepres.2005.08.012
Ogata, Kei, et al. "Timing of interferon therapy and sources of infection in patients with acute hepatitis C." Hepatology research : the official journal of the Japan Society of Hepatology vol. 34,1 (2006): 35-40. doi: https://doi.org/10.1016/j.hepres.2005.08.012
Ogata K, Ide T, Kumashiro R, Kumada H, Yotsuyanagi H, Okita K, Akahane Y, Kaneko S, Tsubouchi H, Tanaka E, Moriwaki H, Nishiguchi S, Kakumu S, Mizokami M, Iino S, Sata M. Timing of interferon therapy and sources of infection in patients with acute hepatitis C. Hepatol Res. 2006 Jan;34(1):35-40. doi: 10.1016/j.hepres.2005.08.012. Epub 2005 Dec 15. PMID: 16359917.
Copy Download .nbib Format: NLM
Spectrophotometric studies on ion-pair extraction equilibria of the iron(ii) and iron(III) complexes with 4-(2-pyridylazo)resorcinol.

Talanta

Hoshino H, Yotsuyanagi T.
PMID: 18963641
Talanta. 1984 Jul;31(7):525-30. doi: 10.1016/0039-9140(84)80133-2.

The ion-pair extraction equilibria of the iron(II) and iron(III) chelates of 4-(2-pyridylazo)resorcinol (PAR, H(2)L) are described. The anionic chelates were extracted into chloroform with benzyldimethyltetradecylammonium chloride (QC1) as counter-ion. The extraction constants were estimated to be K(ex1)(Fe(II)) = [Q{Fe(II)(HL)L}](0)/[Q(+)][{Fe(II)(HL)L}(-)]...

Cite
Hoshino H, Yotsuyanagi T. Spectrophotometric studies on ion-pair extraction equilibria of the iron(ii) and iron(III) complexes with 4-(2-pyridylazo)resorcinol. Talanta. 1984;31(7):525-30doi: 10.1016/0039-9140(84)80133-2.
Hoshino, H., & Yotsuyanagi, T. (1984). Spectrophotometric studies on ion-pair extraction equilibria of the iron(ii) and iron(III) complexes with 4-(2-pyridylazo)resorcinol. Talanta, 31(7), 525-30. https://doi.org/10.1016/0039-9140(84)80133-2
Hoshino, H, and Yotsuyanagi, T. "Spectrophotometric studies on ion-pair extraction equilibria of the iron(ii) and iron(III) complexes with 4-(2-pyridylazo)resorcinol." Talanta vol. 31,7 (1984): 525-30. doi: https://doi.org/10.1016/0039-9140(84)80133-2
Hoshino H, Yotsuyanagi T. Spectrophotometric studies on ion-pair extraction equilibria of the iron(ii) and iron(III) complexes with 4-(2-pyridylazo)resorcinol. Talanta. 1984 Jul;31(7):525-30. doi: 10.1016/0039-9140(84)80133-2. PMID: 18963641.
Copy Download .nbib Format: NLM
The equilibrium constants of cadmium(II)-, lead(II)-, magnesium(II)-, and zinc(II)-alpha,beta,gamma,delta-tetrakis(1-methylpyridinium-4-yl)porphine complexes.

Talanta

Igarashi S, Suzuki H, Yotsuyanagi T.
PMID: 18966344
Talanta. 1995 Aug;42(8):1171-7. doi: 10.1016/0039-9140(95)01564-r.

The equilibrium constants of alpha,beta,gamma,delta-tetrakis(1-methylpyridinium-4-yl)porphine (TMPyP) complexes of cadmium(II), lead(II), magnesium(II), and zinc(II) were spectrophotometrically determined using the absorption spectra at the Soret band and the fluorescence spectra. The values of the following constants at 25 degrees C and...

Cite
Igarashi S, Suzuki H, Yotsuyanagi T. The equilibrium constants of cadmium(II)-, lead(II)-, magnesium(II)-, and zinc(II)-alpha,beta,gamma,delta-tetrakis(1-methylpyridinium-4-yl)porphine complexes. Talanta. 1995;42(8):1171-7doi: 10.1016/0039-9140(95)01564-r.
Igarashi, S., Suzuki, H., & Yotsuyanagi, T. (1995). The equilibrium constants of cadmium(II)-, lead(II)-, magnesium(II)-, and zinc(II)-alpha,beta,gamma,delta-tetrakis(1-methylpyridinium-4-yl)porphine complexes. Talanta, 42(8), 1171-7. https://doi.org/10.1016/0039-9140(95)01564-r
Igarashi, S, et al. "The equilibrium constants of cadmium(II)-, lead(II)-, magnesium(II)-, and zinc(II)-alpha,beta,gamma,delta-tetrakis(1-methylpyridinium-4-yl)porphine complexes." Talanta vol. 42,8 (1995): 1171-7. doi: https://doi.org/10.1016/0039-9140(95)01564-r
Igarashi S, Suzuki H, Yotsuyanagi T. The equilibrium constants of cadmium(II)-, lead(II)-, magnesium(II)-, and zinc(II)-alpha,beta,gamma,delta-tetrakis(1-methylpyridinium-4-yl)porphine complexes. Talanta. 1995 Aug;42(8):1171-7. doi: 10.1016/0039-9140(95)01564-r. PMID: 18966344.
Copy Download .nbib Format: NLM
Amino acid substitutions in the S region of hepatitis B virus in sera from patients with acute hepatitis.

Hepatology research : the official journal of the Japan Society of Hepatology

Aono J, Yotsuyanagi H, Miyoshi H, Tsutsumi T, Fujie H, Shintani Y, Moriya K, Okuse C, Suzuki M, Yasuda K, Iino S, Koike K.
PMID: 17559423
Hepatol Res. 2007 Sep;37(9):731-9. doi: 10.1111/j.1872-034X.2007.00120.x. Epub 2007 Jun 07.

BACKGROUND: An increase in the number of acute hepatitis patients with hepatitis B virus (HBV) of non-indigenous genotypes may reduce the efficacy of vaccination against HBV.METHODS: We have determined the amino acid (aa) sequences in the major hydrophilic region...

Cite
Aono J, Yotsuyanagi H, Miyoshi H, et al. Amino acid substitutions in the S region of hepatitis B virus in sera from patients with acute hepatitis. Hepatol Res. 2007;37(9):731-9doi: 10.1111/j.1872-034X.2007.00120.x.
Aono, J., Yotsuyanagi, H., Miyoshi, H., Tsutsumi, T., Fujie, H., Shintani, Y., Moriya, K., Okuse, C., Suzuki, M., Yasuda, K., Iino, S., & Koike, K. (2007). Amino acid substitutions in the S region of hepatitis B virus in sera from patients with acute hepatitis. Hepatology research : the official journal of the Japan Society of Hepatology, 37(9), 731-9. https://doi.org/10.1111/j.1872-034X.2007.00120.x
Aono, Junko, et al. "Amino acid substitutions in the S region of hepatitis B virus in sera from patients with acute hepatitis." Hepatology research : the official journal of the Japan Society of Hepatology vol. 37,9 (2007): 731-9. doi: https://doi.org/10.1111/j.1872-034X.2007.00120.x
Aono J, Yotsuyanagi H, Miyoshi H, Tsutsumi T, Fujie H, Shintani Y, Moriya K, Okuse C, Suzuki M, Yasuda K, Iino S, Koike K. Amino acid substitutions in the S region of hepatitis B virus in sera from patients with acute hepatitis. Hepatol Res. 2007 Sep;37(9):731-9. doi: 10.1111/j.1872-034X.2007.00120.x. Epub 2007 Jun 07. PMID: 17559423.
Copy Download .nbib Format: NLM
Imported Tungiasis in a Non-endemic Country.

Internal medicine (Tokyo, Japan)

Adachi E, Miharu Y, Suzuki M, Yotsuyanagi H.
PMID: 29984767
Intern Med. 2018 Dec 01;57(23):3497-3498. doi: 10.2169/internalmedicine.1314-18. Epub 2018 Jul 06.

No abstract available.

Cite
Adachi E, Miharu Y, Suzuki M, et al. Imported Tungiasis in a Non-endemic Country. Intern Med. 2018;57(23):3497-3498doi: 10.2169/internalmedicine.1314-18.
Adachi, E., Miharu, Y., Suzuki, M., & Yotsuyanagi, H. (2018). Imported Tungiasis in a Non-endemic Country. Internal medicine (Tokyo, Japan), 57(23), 3497-3498. https://doi.org/10.2169/internalmedicine.1314-18
Adachi, Eisuke, et al. "Imported Tungiasis in a Non-endemic Country." Internal medicine (Tokyo, Japan) vol. 57,23 (2018): 3497-3498. doi: https://doi.org/10.2169/internalmedicine.1314-18
Adachi E, Miharu Y, Suzuki M, Yotsuyanagi H. Imported Tungiasis in a Non-endemic Country. Intern Med. 2018 Dec 01;57(23):3497-3498. doi: 10.2169/internalmedicine.1314-18. Epub 2018 Jul 06. PMID: 29984767; PMCID: PMC6306523.
Copy Download .nbib Format: NLM
Resistance mutations of hepatitis B virus in entecavir-refractory patients.

Hepatology communications

Yamada N, Sugiyama R, Nitta S, Murayama A, Kobayashi M, Okuse C, Suzuki M, Yasuda K, Yotsuyanagi H, Moriya K, Koike K, Wakita T, Kato T.
PMID: 29404449
Hepatol Commun. 2017 Mar 09;1(2):110-121. doi: 10.1002/hep4.1022. eCollection 2017 Apr.

The emergence of resistance mutations in the reverse transcriptase gene of hepatitis B virus (HBV) is associated with treatment failure. Entecavir (ETV) is one of the most potent anti-HBV reagents; it has a very low resistance rate and is...

Cite
Yamada N, Sugiyama R, Nitta S, et al. Resistance mutations of hepatitis B virus in entecavir-refractory patients. Hepatol Commun. 2017;1(2):110-121doi: 10.1002/hep4.1022.
Yamada, N., Sugiyama, R., Nitta, S., Murayama, A., Kobayashi, M., Okuse, C., Suzuki, M., Yasuda, K., Yotsuyanagi, H., Moriya, K., Koike, K., Wakita, T., & Kato, T. (2017). Resistance mutations of hepatitis B virus in entecavir-refractory patients. Hepatology communications, 1(2), 110-121. https://doi.org/10.1002/hep4.1022
Yamada, Norie, et al. "Resistance mutations of hepatitis B virus in entecavir-refractory patients." Hepatology communications vol. 1,2 (2017): 110-121. doi: https://doi.org/10.1002/hep4.1022
Yamada N, Sugiyama R, Nitta S, Murayama A, Kobayashi M, Okuse C, Suzuki M, Yasuda K, Yotsuyanagi H, Moriya K, Koike K, Wakita T, Kato T. Resistance mutations of hepatitis B virus in entecavir-refractory patients. Hepatol Commun. 2017 Mar 09;1(2):110-121. doi: 10.1002/hep4.1022. eCollection 2017 Apr. PMID: 29404449; PMCID: PMC5721430.
Copy Download .nbib Format: NLM
Impact of Obesity and Heavy Alcohol Consumption on Hepatocellular Carcinoma Development after HCV Eradication with Antivirals.

Liver cancer

Minami T, Tateishi R, Fujiwara N, Nakagomi R, Nakatsuka T, Sato M, Uchino K, Enooku K, Nakagawa H, Fujinaga H, Izumiya M, Hanajiri K, Asaoka Y, Kondo Y, Tanaka Y, Otsuka M, Ohki T, Arai M, Tanaka A, Yasuda K, Miura H, Ogata I, Kamoshida T, Inoue K, Koike Y, Akamatsu M, Mitsui H, Fujie H, Ogura K, Yoshida H, Wada T, Kurai K, Maekawa H, Obi S, Teratani T, Masaki N, Nagashima K, Ishikawa T, Kato N, Moriya K, Yotsuyanagi H, Koike K.
PMID: 34414119
Liver Cancer. 2021 Jul;10(4):309-319. doi: 10.1159/000513705. Epub 2021 Jun 04.

BACKGROUND AND AIMS: It remains unclear whether obesity increases the risk of hepatocellular carcinoma (HCC) in patients with chronic hepatitis C who achieved a sustained virological response (SVR) with antiviral therapy.METHODS: In this multicenter cohort study, we enrolled patients...

Cite
Minami T, Tateishi R, Fujiwara N, et al. Impact of Obesity and Heavy Alcohol Consumption on Hepatocellular Carcinoma Development after HCV Eradication with Antivirals. Liver Cancer. 2021;10(4):309-319doi: 10.1159/000513705.
Minami, T., Tateishi, R., Fujiwara, N., Nakagomi, R., Nakatsuka, T., Sato, M., Uchino, K., Enooku, K., Nakagawa, H., Fujinaga, H., Izumiya, M., Hanajiri, K., Asaoka, Y., Kondo, Y., Tanaka, Y., Otsuka, M., Ohki, T., Arai, M., Tanaka, A., Yasuda, K., Miura, H., Ogata, I., Kamoshida, T., Inoue, K., Koike, Y., Akamatsu, M., Mitsui, H., Fujie, H., Ogura, K., Yoshida, H., Wada, T., Kurai, K., Maekawa, H., Obi, S., Teratani, T., Masaki, N., Nagashima, K., Ishikawa, T., Kato, N., Moriya, K., Yotsuyanagi, H., & Koike, K. (2021). Impact of Obesity and Heavy Alcohol Consumption on Hepatocellular Carcinoma Development after HCV Eradication with Antivirals. Liver cancer, 10(4), 309-319. https://doi.org/10.1159/000513705
Minami, Tatsuya, et al. "Impact of Obesity and Heavy Alcohol Consumption on Hepatocellular Carcinoma Development after HCV Eradication with Antivirals." Liver cancer vol. 10,4 (2021): 309-319. doi: https://doi.org/10.1159/000513705
Minami T, Tateishi R, Fujiwara N, Nakagomi R, Nakatsuka T, Sato M, Uchino K, Enooku K, Nakagawa H, Fujinaga H, Izumiya M, Hanajiri K, Asaoka Y, Kondo Y, Tanaka Y, Otsuka M, Ohki T, Arai M, Tanaka A, Yasuda K, Miura H, Ogata I, Kamoshida T, Inoue K, Koike Y, Akamatsu M, Mitsui H, Fujie H, Ogura K, Yoshida H, Wada T, Kurai K, Maekawa H, Obi S, Teratani T, Masaki N, Nagashima K, Ishikawa T, Kato N, Moriya K, Yotsuyanagi H, Koike K. Impact of Obesity and Heavy Alcohol Consumption on Hepatocellular Carcinoma Development after HCV Eradication with Antivirals. Liver Cancer. 2021 Jul;10(4):309-319. doi: 10.1159/000513705. Epub 2021 Jun 04. PMID: 34414119; PMCID: PMC8339497.
Copy Download .nbib Format: NLM
The Japanese Medical Science Federation COVID-19 Expert Opinion English Version.

JMA journal

Nangaku M, Kadowaki T, Yotsuyanagi H, Ohmagari N, Egi M, Sasaki J, Sakamoto T, Hasegawa Y, Ogura T, Chiba S, Node K, Suzuki R, Yamaguchi Y, Murashima A, Ikeda N, Morishita E, Yuzawa K, Moriuchi H, Hayakawa S, Nishi D, Irisawa A, Miyamoto T, Suzuki H, Sone H, Fujino Y.
PMID: 33997449
JMA J. 2021 Apr 15;4(2):148-162. doi: 10.31662/jmaj.2021-0002. Epub 2021 Apr 08.

In 2020, the COVID-19 pandemic has had unprecedented impacts on various aspects of the world. Each academic society has published a guide and/or guidelines on how to cope with COVID-19 separately. As the one and only nationwide association of...

Cite
Nangaku M, Kadowaki T, Yotsuyanagi H, et al. The Japanese Medical Science Federation COVID-19 Expert Opinion English Version. JMA J. 2021;4(2):148-162doi: 10.31662/jmaj.2021-0002.
Nangaku, M., Kadowaki, T., Yotsuyanagi, H., Ohmagari, N., Egi, M., Sasaki, J., Sakamoto, T., Hasegawa, Y., Ogura, T., Chiba, S., Node, K., Suzuki, R., Yamaguchi, Y., Murashima, A., Ikeda, N., Morishita, E., Yuzawa, K., Moriuchi, H., Hayakawa, S., Nishi, D., Irisawa, A., Miyamoto, T., Suzuki, H., Sone, H., & Fujino, Y. (2021). The Japanese Medical Science Federation COVID-19 Expert Opinion English Version. JMA journal, 4(2), 148-162. https://doi.org/10.31662/jmaj.2021-0002
Nangaku, Masaomi, et al. "The Japanese Medical Science Federation COVID-19 Expert Opinion English Version." JMA journal vol. 4,2 (2021): 148-162. doi: https://doi.org/10.31662/jmaj.2021-0002
Nangaku M, Kadowaki T, Yotsuyanagi H, Ohmagari N, Egi M, Sasaki J, Sakamoto T, Hasegawa Y, Ogura T, Chiba S, Node K, Suzuki R, Yamaguchi Y, Murashima A, Ikeda N, Morishita E, Yuzawa K, Moriuchi H, Hayakawa S, Nishi D, Irisawa A, Miyamoto T, Suzuki H, Sone H, Fujino Y. The Japanese Medical Science Federation COVID-19 Expert Opinion English Version. JMA J. 2021 Apr 15;4(2):148-162. doi: 10.31662/jmaj.2021-0002. Epub 2021 Apr 08. PMID: 33997449; PMCID: PMC8118966.
Copy Download .nbib Format: NLM
Intravenous Infusion of Mesenchymal Stem Cells Promotes the Survival of Random Pattern Flaps in Rats.

Plastic and reconstructive surgery

Nakagawa T, Sasaki M, Kataoka-Sasaki Y, Yotsuyanagi T, Radtke C, Kocsis JD, Honmou O.
PMID: 34550936
Plast Reconstr Surg. 2021 Oct 01;148(4):799-807. doi: 10.1097/PRS.0000000000008327.

BACKGROUND: Surgical reconstruction options of soft-tissue defects often include random pattern skin flaps. Flap survival depends on flap size and rotation arc and can be challenging regarding flap perfusion, leading to wound healing complications, insufficient wound coverage, and even...

Cite
Nakagawa T, Sasaki M, Kataoka-Sasaki Y, et al. Intravenous Infusion of Mesenchymal Stem Cells Promotes the Survival of Random Pattern Flaps in Rats. Plast Reconstr Surg. 2021;148(4):799-807doi: 10.1097/PRS.0000000000008327.
Nakagawa, T., Sasaki, M., Kataoka-Sasaki, Y., Yotsuyanagi, T., Radtke, C., Kocsis, J. D., & Honmou, O. (2021). Intravenous Infusion of Mesenchymal Stem Cells Promotes the Survival of Random Pattern Flaps in Rats. Plastic and reconstructive surgery, 148(4), 799-807. https://doi.org/10.1097/PRS.0000000000008327
Nakagawa, Tsugufumi, et al. "Intravenous Infusion of Mesenchymal Stem Cells Promotes the Survival of Random Pattern Flaps in Rats." Plastic and reconstructive surgery vol. 148,4 (2021): 799-807. doi: https://doi.org/10.1097/PRS.0000000000008327
Nakagawa T, Sasaki M, Kataoka-Sasaki Y, Yotsuyanagi T, Radtke C, Kocsis JD, Honmou O. Intravenous Infusion of Mesenchymal Stem Cells Promotes the Survival of Random Pattern Flaps in Rats. Plast Reconstr Surg. 2021 Oct 01;148(4):799-807. doi: 10.1097/PRS.0000000000008327. PMID: 34550936.
Copy Download .nbib Format: NLM
[Pulmonary Epithelioid Hemangioendothelioma:Report of a Case].

Kyobu geka. The Japanese journal of thoracic surgery

Abe M, Yatsuyanagi E, Sato K.
PMID: 34876544
Kyobu Geka. 2021 Dec;74(13):1118-1121.

A 54-year-old woman with a lung tumor was admitted to our hospital for surgical treatment. Chest computed tomography (CT) showed a 16×14×10 mm nodule in left upper lobe. Flurodeoxyglucose (FDG)-positron emission tomography (PET)/CT revealed increased uptake in the nodule....

Cite
Abe M, Yatsuyanagi E, Sato K. [Pulmonary Epithelioid Hemangioendothelioma:Report of a Case]. Kyobu Geka. 2021;74(13):1118-1121
Abe, M., Yatsuyanagi, E., & Sato, K. (2021). [Pulmonary Epithelioid Hemangioendothelioma:Report of a Case]. Kyobu geka. The Japanese journal of thoracic surgery, 74(13), 1118-1121.
Abe, Masahiro, et al. "[Pulmonary Epithelioid Hemangioendothelioma:Report of a Case]." Kyobu geka. The Japanese journal of thoracic surgery vol. 74,13 (2021): 1118-1121.
Abe M, Yatsuyanagi E, Sato K. [Pulmonary Epithelioid Hemangioendothelioma:Report of a Case]. Kyobu Geka. 2021 Dec;74(13):1118-1121. Japanese. PMID: 34876544.
Copy Download .nbib Format: NLM
Malaria Parasites Hijack Host Receptors From Exosomes to Capture Lipoproteins.

Frontiers in cell and developmental biology

Iso-O N, Komatsuya K, Tokumasu F, Isoo N, Ishigaki T, Yasui H, Yotsuyanagi H, Hara M, Kita K.
PMID: 34858976
Front Cell Dev Biol. 2021 Nov 11;9:749153. doi: 10.3389/fcell.2021.749153. eCollection 2021.

Malaria parasites cannot multiply in host erythrocytes without cholesterol because they lack complete sterol biosynthesis systems. This suggests parasitized red blood cells (pRBCs) need to capture host sterols, but its mechanism remains unknown. Here we identified a novel high-density...

Cite
Iso-O N, Komatsuya K, Tokumasu F, et al. Malaria Parasites Hijack Host Receptors From Exosomes to Capture Lipoproteins. Front Cell Dev Biol. 2021;9:749153doi: 10.3389/fcell.2021.749153.
Iso-O, N., Komatsuya, K., Tokumasu, F., Isoo, N., Ishigaki, T., Yasui, H., Yotsuyanagi, H., Hara, M., & Kita, K. (2021). Malaria Parasites Hijack Host Receptors From Exosomes to Capture Lipoproteins. Frontiers in cell and developmental biology, 9749153. https://doi.org/10.3389/fcell.2021.749153
Iso-O, Naoyuki, et al. "Malaria Parasites Hijack Host Receptors From Exosomes to Capture Lipoproteins." Frontiers in cell and developmental biology vol. 9 (2021): 749153. doi: https://doi.org/10.3389/fcell.2021.749153
Iso-O N, Komatsuya K, Tokumasu F, Isoo N, Ishigaki T, Yasui H, Yotsuyanagi H, Hara M, Kita K. Malaria Parasites Hijack Host Receptors From Exosomes to Capture Lipoproteins. Front Cell Dev Biol. 2021 Nov 11;9:749153. doi: 10.3389/fcell.2021.749153. eCollection 2021. PMID: 34858976; PMCID: PMC8631964.
Copy Download .nbib Format: NLM
Showing 25 to 36 of 82 entries